Anne Koivisto (FI)
Read about Anne Koivisto here
Anne-Rita Øksengård (NO)
As Head of Research at The Norwegian Health Association, the Norwegian patient interest organization, I bring a background as a neuro-geriatrician and PhD with extensive clinical and academic experience. My work has been deeply shaped by the patients and their family members I have encountered, inspiring a commitment to fostering collaborative research partnerships. I strive to bring together skilled professionals and individuals with lived experience of dementia to drive innovation in the detection, prevention, diagnosis, and treatment of dementia. My ambition is to facilitate meaningful interaction and discovery that advances our understanding and care of dementia.
Bjørn Hofmann (NO)
Bjørn Hofmann is a Norwegian professor in philosophy of medicine and bioethics with special interest for the relationship between epistemology and ethics. He is affiliated with and the Centre for Medical Ethics at the University of Oslo in Norway and the Department of Health Science at the Norwegian University of Science and Technology (NTNU) at Gjøvik.
Dag Årsland (NO)
Read about Dag Årsland here
Eino Solje (FI)
Dr. Eino Solje is an associate professor at the University of Eastern Finland (UEF) and acts as a Deputy Chief Neurologist at the Neurology Clinic of Kuopio University Hospital, responsible for neurodegenerative diseases. He leads the Brain Research Unit at the UEF. Solje’s research focuses on early-onset dementia.
Hanneke Rhodius-Meester (NO/NL)
Hanneke is a clinical geriatrician. She works both at the Alzheimer Center Amsterdam, and at the Memory Clinic at Ullevål, Oslo University Hospital, combining patient care and research. Her research focus is on digital tools in daily clinical practice, aiming to improve diagnosis and care.
Heikki Tanila (FI)
Heikki Tanila (MD, PhD) is professor of translational neuroscience at A. I. Virtanen Institute at the University of Eastern Finland. He has over 25 years of experience in preclinical studies on the mechanisms of Alzheimer’s disease and therapeutic interventions. His research group utilizes various genetically modified mouse disease models and combines behavioral, electrophysiological, and histopathological approaches.
Henrik Zetterberg (SE)
Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg, Sweden. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, leads the UK DRI Fluid Biomarker Laboratory at UCL, and is a Key Member of the Hong Kong Center for Neurodegenerative Diseases and a Visiting Professor in the UW Department of Medicine, School of Medicine and Public Health, Madison, Wisconsin. His main research focus and clinical interest are fluid biomarkers for brain diseases, neurodegenerative diseases in particular.
Ingmar Skoog (SE)
Jaakko Hotta (FI)
Dr. Jaakko Hotta is a neurologist with a PhD and a clinical subspecialty in memory disorders. Since 2017, Dr. Hotta has been working at the Helsinki University Hospital outpatient clinic, focusing on diagnosing and treating memory disorders. Initially, Dr. Hotta’s research centered on functional brain imaging in chronic pain. However, in recent years, his focus has shifted to memory disorders, particularly the early phases and early detection of these conditions. His current research involves studying mild cognitive impairment (MCI) and subjective cognitive impairment (SCI) using novel techniques such as magnetoencephalography (MEG). In addition to his clinical and research work, Dr. Hotta is dedicated to public education. He chairs a national workgroup that publishes reliable information on memory disorders, including symptoms, diagnostic paths, and treatment options, on the online health service Terveyskylä.fi, developed by Finland’s university hospitals.
Johanna Krüger (FI)
Dr. Johanna Krüger is a neurologist with special competence in memory disorders and medical education. She works as Senior Consultant Neurologist at the Memory Clinic of Oulu University Hospital and as clinical lecturer and director of the Early onset dementia research group at the University of Oulu, Finland. She is chair of Finnish Alzheimer’s Disease Research Society and vice chair of Finland’s National Medical Committee evaluating special competencies in memory disorders. Her research focuses on epidemiology, early diagnostics and biomarkers of early onset dementia with special interest in Alzheimer’s disease and FTD.
Kristian Steen Frederiksen (DK)
Read more about Kristian Steen Frederiksen here
Linus Jönsson (SE)
Dr Linus Jönsson is professor of Health Economics at the department of Neurobiology, Care Sciences and Society at Karolinska Institutet. He is a licensed physician with an interest in the introduction of new medical technologies, and how this can be supported by economic evaluations and clinical decision support tools. His research has focused on health technology assessment and economic evaluation in a range of disease areas but with specific focus on Alzheimer’s disease. Dr Jönsson is the author of over 100 original publications, reviews and book chapters and he has served as scientific advisor to the National Board on Health and Welfare and the Swedish government. He is an affiliated researcher at the Karolinska Institute and co-organizes the International Pharmacoeconomic Conference on Alzheimer’s Disease.
Maria Eriksdotter (SE)
Maria Eriksdotter, MD, PhD, is professor in geriatric medicine at Karolinska Institutet and senior consultant at Karolinska university hospital, Stockholm, Sweden.
Dean of Karolinska Institutet 2019-2023. Chair of the KI department of Neurobiology, care sciences and society 2013-2018.
ME is the founder and the director of the Swedish national quality registry on cognitive/dementia disorders (SveDem, www.svedem.se), now the largest database in the world on different dementia disorders in routine clinical care. She pioneered the first clinical trial in the world on implanted cells releasing nerve growth factor directly to the alzheimer brain and has contributed new knowledge on the long-term cognitive, survival and comorbidity effects of cholinesterase-inhibitors and published > 300 peer-reviewed research articles.
Marwan Noel Sabbagh (US)
Marwan Noel Sabbagh, MD, board certified neurologist and geriatric neurologist, has dedicated his career to finding a cure for Alzheimer’s and other age-related neurodegenerative diseases.
Dr. Sabbagh is a leading investigator for many prominent national Alzheimer’s treatment trials. Dr. Sabbagh is on the editorial board for Journal of Alzheimer’s Disease and Alzheimer’s and Dementia TRCI. He is editor-in-chief of Neurology and Therapy. He has authored and co-authored over 450 medical and scientific articles on Alzheimer’s research.
Dr. Sabbagh is the author of The Alzheimer’s Answer: Reduce Your Risk and Keep Your Brain Healthy, with foreword by Justice Sandra Day O’Connor, and of The Alzheimer’s Prevention Cookbook: 100 Recipes to Boost Brain Health. He has edited Palliative Care for Advanced Alzheimer’s and Dementia: Guidelines and Standards for Evidence Based Care and Geriatric Neurology, published in 2014 and Fighting for my Life: living in the shadow of Alzheimer’s disease in 2019 and Strong Heart, Sharp Mind published in 2022.
Dr. Sabbagh earned his undergraduate degree from the University of California, Berkeley and his medical degree from the University of Arizona in Tucson. He received his residency training in neurology at Baylor College of Medicine, Houston, Texas, and completed his fellowship in geriatric neurology and dementia at the University of California, San Diego School of Medicine, where he served on the faculty as assistant professor.
Before joining the faculty of the Barrow Neurological Institute, he was the Camille and Larry Ruvo Endowed Chair for Brain Health, the Director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas and the founding Principal Investigator of the NIH funded Nevada Exploratory Alzheimer’s Disease Research Center. From 2000-2015, he was the director of the Banner Sun Health Research Institute in Sun City AZ. From 2015-2018, he was the Karsten Solheim Endowed Chair for Alzheimer’s research at the Barrow Neurological Institute. Presently, in addition to being vice chair, he also serves as Associate Program Director for Research for the Neurology Residency
Miia Kivipelto (FI/SE)
Miia Kivipelto, MD, PhD, is Professor of Clinical Geriatrics at Karolinska Institutet and senior geriatrician and Director for Research & Development of Theme Aging at Karolinska University Hospital. Dr Kivipelto’s translational research focuses on the prevention, early diagnosis and treatment of cognitive impairment, dementia and Alzheimer’s disease. She is the PI of the landmark FINGER trial, and she has founded the World Wide FINGERS network and FINGERS Brain Health Institute.
Niklas Mattsson-Carlgren (SE)
Niklas Mattsson-Carlgren, MD, PhD, is an associate professor of clinical neuroscience at Lund University, a specialist in neurology at the Memory Clinic at Skåne University Hospital Malmö, and one of the leaders of the Swedish BioFINDER studies in Lund and Malmö.. His research is mainly focused on Alzheimer’s disease and other neurodegenerative and neurological diseases. His main aims to improve diagnostic and prognostic methods, improve design of clinical trials, and gain novel understanding of disease mechanisms. Niklas is also a board certified specialist in clinical chemistry, and his research has influenced the use of biomarkers in AD diagnostics and prognostics, in both research, clinical practice, and drug development. For example, he has contributed to the development of efficient plasma-based measures to diagnose and prognosticate AD, already from pre-symptomatic disease stages. He has also integrated fluid measures with neuroimaging and genetics to increase our understanding of clincially relevant disease mechanisms in AD. He has worked with neurological diseases as a PhD-student at University of Gothenburg 2006-2012, as a postdoc at University of California San Francisco 2012-2015, and as researcher and clinician at Lund University and Skåne University Hospital since 2015.
Riitta Parkkola (FI)
Ritta Parkkola is a professor of radiology and senior consulting neuroradiologist at the Turku University Hospital. Her research is focused on brain MRI and carbo-metabolic imaging. She has 306 publications on PubMed, and her Hirsch-index is 56.
Silke Kern (SE)
Read more about Silke Kern here
Tiago Gil Oliveira (PT)
Tiago Gil Oliveira is Associate Professor at the School of Medicine, at University of Minho, research line coordinator at the Life and Health Sciences Research Institute (ICVS), neuroradiologist at Hospital de Braga and President of the Portuguese Society for Neuroscience. He was a student in the joint Minho MD/PhD program with Columbia University, NYC, USA. He carried out his PhD studies at Columbia University, between 2007 and 2010, and MD studies at University of Minho. While studying the role of lipid signaling in Alzheimer’s disease pathogenesis, he showed that the ablation of the lipid-modulating enzyme, phospholipase D2, was protective in different Alzheimer’s disease models. He then expanded his research interests to the study of mood disorders and brain plasticity mechanisms. In parallel with his academic work, he continued his medical career. He is now using lipidomic approaches together with brain imaging to study neurodegenerative disorders. He is also a site researcher involved in various clinical trials focused on neurodegenerative disorders and he has a particular interest in the mechanisms underlying amyloid-related imaging abnormalities (ARIA).
Tobias Granberg (SE)
Tobias Granberg, MD, PhD, is Adjunct Professor of Neuroradiology and the Scientific Director of the MRI Center Core Facility at Karolinska Institutet. He is also Section Head of Neuroradiology at Karolinska University Hospital, where he has developed extensive experience in neuroradiological ARIA reads for clinical trials. Prof. Granberg is the Scientific Secretary of the Swedish Society of Neuroradiology and has led national work on MRI protocols and reporting templates, including those for dementia investigations and ARIA monitoring.
Tormod Fladby (NO)
Tormod Fladby (MD, PhD) is head of the Department of Neurology, Akershus University Hospital and a professor at the Institute of Clinical Medicine, University of Oslo. His research concerns cognitive impairment in Alzheimer’s disease, biomarkers and imaging diagnostics as well as clinical trials and development of treatments.
